GlycoMimetics
Stock Forecast, Prediction & Price Target
GlycoMimetics Financial Estimates
GlycoMimetics Revenue Estimates
GlycoMimetics EBITDA Estimates
GlycoMimetics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $1.16M N/A | $74.92K -93.54% | $10K -86.65% | Avg: $2.67M Low: $2.67M High: $2.67M avg. 26625% | Avg: $950K Low: $950K High: $950K avg. -64.45% | Avg: $5.53M Low: $5.53M High: $5.53M avg. 482.63% | Avg: $37.15M Low: $37.15M High: $37.15M avg. 571.18% |
Net Income
% change YoY
| $-63.14M N/A | $-93.32M -47.80% | $-36.89M 60.46% | Avg: $-40.50M Low: $-57.00M High: $-5.06M avg. -9.77% | Avg: $-45.45M Low: $-91.84M High: $-5.06M avg. -12.22% | Avg: $-80.12M Low: $-80.12M High: $-80.12M avg. -76.27% | Avg: $-67.77M Low: $-67.77M High: $-67.77M avg. 15.41% |
EBITDA
% change YoY
| $-63.44M N/A | $-47.40M 25.28% | $-39.12M 17.46% | Avg: $-1.60M Low: $-1.60M High: $-1.60M avg. 95.90% | Avg: $-570K Low: $-570K High: $-570K avg. 64.45% | Avg: $-3.32M Low: $-3.32M High: $-3.32M avg. -482.63% | Avg: $-22.29M Low: $-22.29M High: $-22.29M avg. -571.18% |
EPS
% change YoY
| -$1.23 N/A | -$1.78 -44.71% | -$0.58 67.41% | Avg: -$0.45 Low: -$0.9 High: -$0.08 avg. 22.41% | Avg: -$0.52 Low: -$1.45 High: -$0.08 avg. -14.99% | Avg: -$1.27 Low: -$1.27 High: -$1.27 avg. -144.44% | Avg: -$1.07 Low: -$1.07 High: -$1.07 avg. 15.41% |
Operating Expenses
% change YoY
| $64.60M N/A | $47.47M -26.51% | $39.28M -17.25% | Avg: $1.16B Low: $1.16B High: $1.16B avg. 2863.54% | Avg: $413.85M Low: $413.85M High: $413.85M avg. -64.45% | Avg: $2.41B Low: $2.41B High: $2.41B avg. 482.63% | Avg: $16.18B Low: $16.18B High: $16.18B avg. 571.18% |
FAQ
What is GlycoMimetics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -20.71% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is -57.00M, average is -40.50M and high is -5.06M.
What is GlycoMimetics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 6903.59% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $2.67M, average is $2.67M and high is $2.67M.
What is GlycoMimetics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -30.40% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$0.9, average is -$0.45 and high is $-0.08.